deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT05065047

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Sponsor: M.D. Anderson Cancer Center

Conditions Multiple Myeloma
Interventions Belantamab mafodotin
Updated 20 times since 2021 Last updated: Nov 10, 2025 Started: Jan 5, 2023 Primary completion: Nov 6, 2025 Completion: Nov 6, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

\<75% participation

Other terminated trials from M.D. Anderson Cancer Center

See all terminations from M.D. Anderson Cancer Center

Other Multiple Myeloma trials with similar outcome

Browse all Multiple Myeloma trials

This PHASE1 trial investigates Multiple Myeloma and is currently terminated or withdrawn. M.D. Anderson Cancer Center leads this study, which shows 20 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Mar 2022 · 4 months · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshot~Jul 2023 – ~Nov 2023 · 4 months · monthly snapshot~Nov 2023 – ~Feb 2024 · 3 months · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~May 2024 · 2 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Jun 2025 · 2 months · monthly snapshot~Jun 2025 – ~Oct 2025 · 4 months · monthly snapshot~Oct 2025 – ~Dec 2025 · 2 months · monthly snapshot~Dec 2025 – present · 9 months · monthly snapshot

Change History

20 versions recorded

  1. Dec 2025 — Present [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  2. Oct 2025 — Dec 2025 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  3. Jun 2025 — Oct 2025 [monthly]

    Recruiting PHASE1

  4. Apr 2025 — Jun 2025 [monthly]

    Recruiting PHASE1

  5. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE1

▶ Show 15 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  2. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE1

  3. May 2024 — Jun 2024 [monthly]

    Recruiting PHASE1

  4. Mar 2024 — May 2024 [monthly]

    Recruiting PHASE1

  5. Feb 2024 — Mar 2024 [monthly]

    Recruiting PHASE1

  6. Nov 2023 — Feb 2024 [monthly]

    Recruiting PHASE1

  7. Jul 2023 — Nov 2023 [monthly]

    Recruiting PHASE1

  8. Feb 2023 — Jul 2023 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2023 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE1

  10. Sep 2022 — Jan 2023 [monthly]

    Not Yet Recruiting PHASE1

  11. Jul 2022 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE1

  12. Apr 2022 — Jul 2022 [monthly]

    Not Yet Recruiting PHASE1

  13. Mar 2022 — Apr 2022 [monthly]

    Not Yet Recruiting PHASE1

  14. Nov 2021 — Mar 2022 [monthly]

    Not Yet Recruiting PHASE1

  15. Oct 2021 — Nov 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations